Investigations
Every investigation we've published, newest first — each one built on primary documents and classified under our evidence standard.
Institutions — 24 September 2024 — 6 min read
Medtronic agreed to pay $9.2 million to the DOJ to resolve False Claims Act allegations that consulting fees and royalty payments to spine surgeons constituted illegal kickbacks that induced them to use Medtronic spinal implants in procedures billed to Medicare and Medicaid.
Read the full report →
Fraud & Deception — 23 September 2024 — 7 min read
The DOJ charged Acuitas Medical and its principals with submitting millions in fraudulent Medicare claims for expensive blood test panels that patients had never requested and physicians had not ordered — a scheme that generated laboratory revenue by running unnecessary tests and billing the federal health program for diagnostic services that had no clinical basis.
Read the full report →
Fraud & Deception — 20 September 2024 — 7 min read
The FTC and SEC alleged Onpassive collected hundreds of millions of dollars from participants through a recruiting-fee pyramid scheme, promising returns from AI-powered marketing software that was never delivered in the form advertised.
Read the full report →
Fraud & Deception — 18 September 2024 — 6 min read
The FTC says Blueprint to Wealth offered essentially no value beyond commissions for recruiting new members. One of its operators is now permanently barred from telemarketing.
Read the full report →
Fraud & Deception — 18 September 2024 — 6 min read
The SEC charged Safe Haven Capital and its manager with raising $22 million from investors using fabricated audit reports and materially false descriptions of the fund's real estate assets and income.
Read the full report →
Corporations — 17 September 2024 — 7 min read
Checkr Inc.'s automated matching algorithms attributed criminal and civil records belonging to one individual to different job applicants with similar names or identifying information, producing reports that harmed applicants who had no such records of their own.
Read the full report →
Corporations — 17 September 2024 — 6 min read
Sterling Infosystems generated employment background reports that attributed criminal and civil records from one individual to a different person with a similar name or date of birth, causing job applicants to be evaluated on records that were not theirs.
Read the full report →
Corporations — 16 September 2024 — 7 min read
The FTC charged Mynd Analytics with sharing sensitive mental health and behavioral health data from its clinical decision support platform with third-party analytics and advertising vendors without the patient notice or consent its privacy policy represented was required — exposing some of the most sensitive health information patients generate to commercial data uses they never authorized.
Read the full report →
Corporations — 12 September 2024 — 7 min read
The DOJ investigated Envision Healthcare, the KKR-backed physician staffing company, over allegations its emergency medicine and anesthesiology groups manipulated billing codes to inflate payments from Medicare and Medicaid.
Read the full report →
Corporations — 11 September 2024 — 7 min read
The FTC found Uber Freight charged trucking carriers fees and deductions not clearly disclosed at the time they accepted loads, reducing their actual net pay below the amounts they agreed to — a practice the agency concluded was deceptive and unfair under federal consumer protection law.
Read the full report →
Corporations — 10 September 2024 — 6 min read
Benefect botanical disinfectant products were subject to enforcement under the Federal Insecticide, Fungicide, and Rodenticide Act after regulatory review found that certain label claims about efficacy and composition were not supported by the documentation required for registered pesticide products.
Read the full report →
Corporations — 5 September 2024 — 7 min read
The SEC charged BioAtla with making materially misleading statements about Phase 1 clinical trial data for its antibody drug conjugate cancer program, finding the company's investor presentations characterized response rate data without adequately disclosing the very limited follow-up duration underlying those results.
Read the full report →